Tactile Medical Q2 FY26 net income more than doubled to $7.8 million; revenue rises 9% to $85.7 million

Second-quarter results

Tactile Systems Technology posted Q2 revenue up 9% to $85.7 million; GAAP net income more than doubled to $7.8 million.

Gross margin widened 1 percentage point to 76%, and adjusted EBITDA climbed to $11.4 million.

Distribution deal and outlook

Tactile Systems Technology entered an exclusive U.S. distribution deal with ElastiMed for MyoSleeve to VA/DoD channels.

The company trimmed its 2026 revenue outlook to $360 million-$366 million and maintained its adjusted EBITDA forecast of $49 million-$51 million.

Airway clearance and product launch activity

Airway clearance revenue fell 7% on temporary inventory management dynamics tied to the next-generation AffloVest launch at some large DME providers.

The company launched the next-generation AffloVest system.

Second-quarter results

Distribution deal and outlook

Airway clearance and product launch activity

Related News

Fermi signs 15-year data center lease with TensorWave worth about $6.5 billion

Flowco declares one-time special dividend of $0.14 per share

Sendas Distribuidora buys back 786,400 shares for R$ 6.68 million

Sources

Tactile Medical Q2 FY26 net income more than doubled to $7.8 million; revenue rises 9% to $85.7 million

Archrock tightens 2026 adjusted EBITDA guidance to $865 million-$885 million

New Concept Energy, Inc. Q2 Revenue USD 41 Thousand